Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease.
Iversen E, Kallemose T, Hornum M, Bengaard AK, Nehlin JO, Rasmussen LJH, Sandholdt H, Tavenier J, Feldt-Rasmussen B, Andersen O, Eugen-Olsen J, Houlind MB.
Iversen E, et al. Among authors: tavenier j.
Clin Kidney J. 2022 Feb 21;15(8):1534-1541. doi: 10.1093/ckj/sfac048. eCollection 2022 Aug.
Clin Kidney J. 2022.
PMID: 35892012
Free PMC article.